News from WCM

Two molecular signaling pathways underlie the cardiac defects associated with one type of the inherited disorder Noonan syndrome (NS), researchers from Masonic Medical Research Institute, Beth Israel Deaconess Medical Center and Weill Cornell Medicine find in a new study.

The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.

A newly available drug may improve the effectiveness of immunotherapy in hard-to-treat cancers of the upper urinary tract, suggests a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A new technology devised by scientists at Weill Cornell Medicine and the New York Genome Center (NYGC) enables the measurement of gene mutations and their effects on gene activity within individual cancer cells biopsied from patients.

Early disruptions in brain cell activity may give rise to autism.

The Executive M.B.A./M.S. in Healthcare Leadership program, offered jointly by the Weill Cornell Graduate School of Medical Sciences and Cornell’s Samuel Curtis Johnson Graduate School of Management in May celebrated a milestone: graduating its first class of 39 students.  

Studying the Fundamentals of Bone Strength, Pathologist Dr.  Matthew Greenblatt Aims to Protect People from Osteoporosis

A physician-author sounds the alarm about drug-resistant bacteria—and shares his own experiences on the front lines of treatment.

Physicians, researchers and policymakers around the globe are grappling with the rise of antibiotic-resistant bacteria—a threat with the potential to derail decades of medical advances.

New federal regulations will dictate when and how physicians can order advanced imaging tests for Medicare patients to prevent unnecessary procedures and curb healthcare spending. These rules will achieve their goals only if providers can devote substantial resources and planning ahead of their implementation in 2020. 

One of the most successful interventions in reducing infectious disease worldwide, vaccination still has limited effectiveness in protecting one group of patients – newborn infants. 

Dr. Jonathan Avery is working to combat stigma within the medical community against patients who struggle with substance use disorders.

Findings from a recent study by a team of Weill Cornell Medicine and NewYork-Presbyterian researchers explain why a bladder cancer patient responded exceptionally well to a targeted drug when others did not. 

More than 370 students celebrated a milestone on May 30: graduating from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences and Weill Cornell Medicine-Qatar. 

On the eve of their commencement, students from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences were recognized for their outstanding achievements.

Dr. Katharine Hsu, M.D. ’94, Ph.D. ’93, professor of medicine and attending physician at Memorial Sloan Kettering Cancer Center, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.

Dr. Allan Ropper, M.D. ’74, has been awarded the Weill Cornell Medicine Alumni Association Award of Distinction.

The event, sponsored by the institution’s BioVenture eLab, is the culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.

For Ngozi Monu, the key to success is balance. By the time she entered medical school, she was a two-time Olympian with a doctorate.

An athlete, artist, writer and scientist, Claire Oh allowed her disparate passions to guide her career.